Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718	11/46	4.921499588969747E-6	0.0017963473499739576	0	0	6.677082337951903	81.6066144605069	EBP;HMGCS1;SCD;CYP51A1;NR1H3;MSMO1;HMGCR;HSD17B7;FADS1;ABCG1;FDFT1
Cholesterol Biosynthesis Pathway WP197	5/15	3.912798958603364E-4	0.07140858099451139	0	0	10.565891472868216	82.90090803834514	HMGCS1;CYP51A1;MSMO1;HMGCR;FDFT1
SREBF and miR33 in cholesterol and lipid homeostasis WP2011	4/16	0.004957332186317436	0.6031420826686215	0	0	7.035398230088496	37.33606726676055	HMGCS1;SCD;NR1H3;HMGCR
Bone morphogenic protein (BMP) signaling and regulation WP1425	3/12	0.015084447806527396	0.9984653905752534	0	0	7.028729281767956	29.479130310016917	SMAD4;NOG;BMPR1B
Cell-type Dependent Selectivity of CCK2R Signaling WP3679	3/13	0.01895842654364398	0.9984653905752534	0	0	6.325524861878453	25.08391168764085	TRPC1;RYR3;GNAI1
Sterol regulatory element-binding proteins (SREBP) signaling WP1982	7/69	0.036600301944871204	0.9984653905752534	0	0	2.3846264007733344	7.887625857456792	HMGCS1;SCD;INSIG1;CYP51A1;HMGCR;LPIN1;FDFT1
Cholesterol Biosynthesis with Skeletal Dysplasias WP4804	2/7	0.03713643458377356	0.9984653905752534	0	0	8.426931567328918	27.751206379134487	EBP;CYP51A1
Hfe effect on hepcidin production WP3924	2/7	0.03713643458377356	0.9984653905752534	0	0	8.426931567328918	27.751206379134487	ID1;BMP6
Mevalonate pathway WP3963	2/7	0.03713643458377356	0.9984653905752534	0	0	8.426931567328918	27.751206379134487	HMGCS1;HMGCR
Genes related to primary cilium development (based on CRISPR) WP4536	9/103	0.044512673879476314	0.9984653905752534	0	0	2.0233119541807683	6.296509014196711	IFT88;IFT81;IFT172;TCTN2;TMEM67;CBY1;BBS9;DYNLL1;TXNDC15
Mitochondrial CII Assembly WP4920	2/8	0.04804895777351683	0.9984653905752534	0	0	7.022075055187638	21.31575343880034	SDHC;SDHA
White fat cell differentiation WP4149	4/32	0.05538769541573418	0.9984653905752534	0	0	3.0126422250316054	8.716772429195021	MECOM;NR1H3;GATA3;GATA2
Imatinib and Chronic Myeloid Leukemia WP3640	3/20	0.0598020163822685	0.9984653905752534	0	0	3.7195320116997075	10.476864957270013	BCR;ABCB1;CDKN1B
Development of ureteric collection system WP5053	5/47	0.0608609883375539	0.9984653905752534	0	0	2.511469704160734	7.030012808102587	MYCN;SMO;GATA3;FAT4;FREM1
Globo Sphingolipid Metabolism WP1424	3/21	0.06749951371198952	0.9984653905752534	0	0	3.512707182320442	9.468976022845567	ST6GAL2;ABO;ST6GALNAC5
Nicotine Activity on Dopaminergic Neurons WP1602	3/21	0.06749951371198952	0.9984653905752534	0	0	3.512707182320442	9.468976022845567	CHRNA5;GNAI1;SLC18A2
Liver X receptor pathway WP2874	2/10	0.07274275372169797	0.9984653905752534	0	0	5.266004415011038	13.801281197935431	SCD;NR1H3
Mevalonate arm of cholesterol biosynthesis pathway WP4190	2/11	0.08630715111831913	0.9984653905752534	0	0	4.680647534952171	11.466850760412164	HMGCS1;HMGCR
Hematopoietic Stem Cell Differentiation WP2849	5/55	0.10343006545487843	0.9984653905752534	0	0	2.10874861572536	4.784454521269968	MUC1;THRB;RHOH;GATA2;ABO
Transcriptional cascade regulating adipogenesis WP4211	2/13	0.11538685882895956	0.9984653905752534	0	0	3.829219345775637	8.269064413027971	GATA3;GATA2
MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301	2/13	0.11538685882895956	0.9984653905752534	0	0	3.829219345775637	8.269064413027971	PRKCQ;RYR3
7-oxo-C and 7beta-HC pathways WP5064	3/27	0.1219686781970972	0.9984653905752534	0	0	2.6337016574585634	5.541284592670695	EBP;ACOT7;EPHX2
Kennedy pathway from sphingolipids WP3933	2/14	0.13072976856922172	0.9984653905752534	0	0	3.5099337748344372	7.1413917119475085	PCYT1B;ETNK2
Omega-9 FA synthesis WP4724	2/14	0.13072976856922172	0.9984653905752534	0	0	3.5099337748344372	7.1413917119475085	SCD;FADS1
Mesodermal commitment pathway WP2857	10/147	0.13224398285438688	0.9984653905752534	0	0	1.5407312275453968	3.117063680970073	ZNF462;SMAD4;MEIS1;ATP8B2;NOG;DNMT3B;HMGA2;TCF4;GATA3;PBX1
Oxysterols derived from cholesterol WP4545	4/46	0.15489526545039176	0.9984653905752534	0	0	2.006953223767383	3.7429799991760895	EBP;ACOT7;INSIG1;EPHX2
ESC Pluripotency Pathways WP3931	8/116	0.15734650402316966	0.9984653905752534	0	0	1.5624691358024692	2.889481787621392	FGF16;FZD3;SMAD4;AKT3;FZD6;NOG;BMPR1B;LRP6
ID signaling pathway WP53	2/16	0.16263853612026213	0.9984653905752534	0	0	3.008199306212551	5.463567117147712	ID1;ID3
Osteoblast differentiation WP4787	8/118	0.16806348326812234	0.9984653905752534	0	0	1.5338989898989899	2.73557615757148	FZD3;SMAD4;SMO;FZD6;PRKCQ;BMPR1B;PRKCZ;LRP6
Ovarian infertility WP34	3/32	0.17604945726523666	0.9984653905752534	0	0	2.1790436273575917	3.7849776793634087	CDKN1B;NRIP1;BMPR1B
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664	2/17	0.17906858479997015	0.9984653905752534	0	0	2.8075055187637967	4.828871285547475	MBOAT1;TCF4
Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786	3/33	0.18756876775023812	0.9984653905752534	0	0	2.1062983425414363	3.5251214203228027	PLOD2;TMEM38B;LRP6
Nuclear Receptors in Lipid Metabolism and Toxicity WP299	3/33	0.18756876775023812	0.9984653905752534	0	0	2.1062983425414363	3.5251214203228027	ABCB1;NR1H3;ABCG1
Pathways in clear cell renal cell carcinoma WP4018	6/85	0.18879725748644405	0.9984653905752534	0	0	1.6009149849841422	2.668855836829162	DEPTOR;SSPN;PLOD2;ALDOC;ENO2;PFKM
Endoderm differentiation WP2853	9/141	0.1917958893170403	0.9984653905752534	0	0	1.4379613712205481	2.3745394746973902	ZNF462;SMAD4;ATP8B2;TCEAL2;NOG;DNMT3B;RAB38;TCF4;PBX1
TCA Cycle (aka Krebs or citric acid cycle) WP78	2/18	0.19573404108341794	0.9984653905752534	0	0	2.631898454746137	4.292622364643218	SDHC;SDHA
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859	2/18	0.19573404108341794	0.9984653905752534	0	0	2.631898454746137	4.292622364643218	SMAD4;ID1
Sulindac Metabolic Pathway WP2542	1/5	0.20732156040762345	0.9984653905752534	0	0	5.26130099228225	8.278574293865114	MSRB3
Vitamin B6-dependent and responsive disorders WP4228	1/5	0.20732156040762345	0.9984653905752534	0	0	5.26130099228225	8.278574293865114	AASS
Linoleic acid metabolism known to be affected by coronavirus infection WP4853	1/5	0.20732156040762345	0.9984653905752534	0	0	5.26130099228225	8.278574293865114	FADS1
miR-517 relationship with ARCN1 and USP1 WP3596	1/5	0.20732156040762345	0.9984653905752534	0	0	5.26130099228225	8.278574293865114	ID1
Ciliopathies WP4803	11/183	0.21073434068046276	0.9984653905752534	0	0	1.3489409141583055	2.100512770451505	SMO;IFT81;IFT172;TCTN2;TMEM67;ARMC4;NPHP3;BBS9;PKD2;TRIM32;ADCY6
Overview of nanoparticle effects WP3287	2/19	0.2125797454730114	0.9984653905752534	0	0	2.4769510453187897	3.8354053411802145	AKT3;PTGS1
Allograft Rejection WP2328	6/89	0.21729915153488247	0.9984653905752534	0	0	1.5234418828306575	2.3255040167095924	PECR;HLA-DRB5;ABCB1;PRKCZ;HLA-DRB1;HLA-DQB1
Wnt signaling in kidney disease WP4150	3/36	0.2231733927106072	0.9984653905752534	0	0	1.9145153189352084	2.871402067607709	FZD3;FZD6;LRP6
Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657	2/20	0.22955505169355017	0.9984653905752534	0	0	2.3392200147167035	3.442425183697611	SMAD4;DNMT3B
Amino Acid metabolism WP3925	6/91	0.23206770675332095	0.9984653905752534	0	0	1.487439676535803	2.1727419732183524	ARG2;HIBADH;ALDH1A1;SDHA;BCAT1;HIBCH
GPCRs, Other WP117	6/91	0.23206770675332095	0.9984653905752534	0	0	1.487439676535803	2.1727419732183524	CHRM3;ADGRG1;SMO;HTR1F;VN1R1;GPR135
Ebola Virus Pathway on Host WP4217	8/129	0.23237212908997532	0.9984653905752534	0	0	1.393645546372819	2.033907476590145	BST2;HLA-DRB5;DDX58;NEDD4;ICAM3;HLA-DRB1;IGF1R;HLA-DQB1
Adipogenesis WP236	8/130	0.2386127382719645	0.9984653905752534	0	0	1.3821493624772314	1.98050031905115	SCD;NRIP1;NDN;ID3;NR1H3;GATA3;GATA2;LPIN1
Calcium Regulation in the Cardiac Cell WP536	9/150	0.2423363556596712	0.9984653905752534	0	0	1.3455375949636712	1.9072034942634644	SLC8A3;CHRM3;PKIA;PRKCQ;GNB5;PRKCZ;RYR3;ADCY6;GNAI1
Somatroph axis (GH) and its relationship to dietary restriction and aging WP4186	1/6	0.24331811129808925	0.9984653905752534	0	0	4.208820286659316	5.948685951529383	IGF1R
LncRNA-mediated mechanisms of therapeutic resistance WP3672	1/6	0.24331811129808925	0.9984653905752534	0	0	4.208820286659316	5.948685951529383	ABCB1
Metabolism of alpha-linolenic acid WP4586	1/6	0.24331811129808925	0.9984653905752534	0	0	4.208820286659316	5.948685951529383	FADS1
Robo4 and VEGF Signaling Pathways Crosstalk WP3943	1/6	0.24331811129808925	0.9984653905752534	0	0	4.208820286659316	5.948685951529383	ROBO4
Urea cycle and metabolism of amino groups WP497	2/21	0.24661353135814304	0.9984653905752534	0	0	2.2159869873358895	3.102232907987064	ARG2;GATM
Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884	2/21	0.24661353135814304	0.9984653905752534	0	0	2.2159869873358895	3.102232907987064	HLA-DRB5;HLA-DRB1
Corticotropin-releasing hormone signaling pathway WP2355	6/93	0.24713911720804824	0.9984653905752534	0	0	1.4530927440935852	2.031138666022546	CRHBP;PRKCQ;TCF4;GNB5;RAPGEF3;GNAI1
G Protein Signaling Pathways WP35	6/93	0.24713911720804824	0.9984653905752534	0	0	1.4530927440935852	2.031138666022546	GNA12;PRKCQ;GNB5;PRKCZ;ADCY6;GNAI1
Thyroid hormones production and their peripheral downstream signaling effects WP4746	6/95	0.2624810591736759	0.9984653905752534	0	0	1.420289494008321	1.899745644557828	RPS6KA6;THRB;AKT3;PRKG2;PRKCQ;SLC16A2
Transcription factor regulation in adipogenesis WP3599	2/22	0.26371269612140075	0.9984653905752534	0	0	2.1050772626931566	2.8058470437371636	NRIP1;LPIN1
Fatty Acid Biosynthesis WP357	2/22	0.26371269612140075	0.9984653905752534	0	0	2.1050772626931566	2.8058470437371636	PECR;SCD
PKC-gamma calcium signaling pathway in ataxia WP4760	2/22	0.26371269612140075	0.9984653905752534	0	0	2.1050772626931566	2.8058470437371636	PLCB4;RYR3
TGF-beta receptor signaling in skeletal dysplasias WP4816	4/58	0.2691755299257002	0.9984653905752534	0	0	1.5599803343166174	2.0473050628659157	SMAD4;NOG;LTBP3;FBN1
Pre-implantation embryo WP3527	4/58	0.2691755299257002	0.9984653905752534	0	0	1.5599803343166174	2.0473050628659157	GATA3;GATA2;E2F5;PBX1
Arachidonate Epoxygenase / Epoxide Hydrolase WP678	1/7	0.27768172953549347	0.9984653905752534	0	0	3.5071664829106948	4.493661145170114	EPHX2
LDLRAD4 and what we know about it WP4904	1/7	0.27768172953549347	0.9984653905752534	0	0	3.5071664829106948	4.493661145170114	NEDD4
MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593	1/7	0.27768172953549347	0.9984653905752534	0	0	3.5071664829106948	4.493661145170114	HES1
SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883	1/7	0.27768172953549347	0.9984653905752534	0	0	3.5071664829106948	4.493661145170114	REN
GDNF/RET signaling axis WP4830	2/23	0.2808137360968808	0.9984653905752534	0	0	2.0047303689687794	2.5461352504749413	GATA3;FAT4
Pathways Regulating Hippo Signaling WP4540	6/98	0.2859299134185274	0.9984653905752534	0	0	1.3737587968765064	1.7199577678046662	PLCB4;PRKCQ;CDH9;PRKCZ;IGF1R;CDH7
Kallmann's Syndrome WP5074	2/24	0.29788127427042116	0.9984653905752534	0	0	1.9135059201284368	2.317371016084043	TMEM98;PRKCQ
TFs regulate miRNAs related to cardiac hypertrophy WP1559	1/8	0.31048641241381475	0.9984653905752534	0	0	3.005985194518822	3.5158457908428145	MYEF2
Phase I biotransformations, non P450 WP136	1/8	0.31048641241381475	0.9984653905752534	0	0	3.005985194518822	3.5158457908428145	ESD
Signal Transduction of S1P Receptor WP26	2/25	0.3148831351305229	0.9984653905752534	0	0	1.8302140320568192	2.1149106122375305	AKT3;GNAI1
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668	2/25	0.3148831351305229	0.9984653905752534	0	0	1.8302140320568192	2.1149106122375305	SMAD4;FBN1
Glioblastoma signaling pathways WP2261	5/82	0.31575660414223133	0.9984653905752534	0	0	1.3673757029238758	1.576288288430308	CDKN1B;AKT3;PRKCQ;PRKCZ;IGF1R
3q29 copy number variation syndrome WP4906	4/63	0.32063805185678096	0.9984653905752534	0	0	1.427403629818509	1.6235893481492012	SLC40A1;RNF8;PIGM;DYNLL1
Endochondral Ossification with Skeletal Dysplasias WP4808	4/64	0.33103879144080534	0.9984653905752534	0	0	1.4035398230088496	1.5516409462279497	IFT88;HMGCS1;BMP6;IGF1R
Endochondral Ossification WP474	4/64	0.33103879144080534	0.9984653905752534	0	0	1.4035398230088496	1.5516409462279497	IFT88;HMGCS1;BMP6;IGF1R
Wnt/beta-catenin signaling pathway in leukemia WP3658	2/26	0.33179012765632077	0.9984653905752534	0	0	1.7538631346578366	1.9349541608130614	FZD6;LRP6
Glycolysis and Gluconeogenesis WP534	3/45	0.33518469529244016	0.9984653905752534	0	0	1.5035516969218627	1.6434926208114553	ALDOC;ENO2;PFKM
Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720	1/9	0.34180280749490594	0.9984653905752534	0	0	2.630099228224917	2.823467528098872	EPHX2
Folate-Alcohol and Cancer Pathway Hypotheses WP1589	1/9	0.34180280749490594	0.9984653905752534	0	0	2.630099228224917	2.823467528098872	ALDH1A1
Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480	1/9	0.34180280749490594	0.9984653905752534	0	0	2.630099228224917	2.823467528098872	MUC1
Aryl Hydrocarbon Receptor Netpath WP2586	3/46	0.34776302539976095	0.9984653905752534	0	0	1.4685082872928177	1.5510883715448087	CDKN1B;NRIP1;NCOA7
1q21.1 copy number variation syndrome WP4905	2/27	0.34857584094564503	0.9984653905752534	0	0	1.6836203090507726	1.7743665200403291	ACP6;NBPF12
Intraflagellar transport proteins binding to dynein WP4532	2/27	0.34857584094564503	0.9984653905752534	0	0	1.6836203090507726	1.7743665200403291	IFT81;DYNLL1
Thyroid stimulating hormone (TSH) signaling pathway WP2032	4/66	0.3518824679375993	0.9984653905752534	0	0	1.3581216100485298	1.4185010580619846	CDKN1B;GNA12;GNAI1;IGF1R
Steroid Biosynthesis WP496	1/10	0.3716983643872405	0.9984653905752534	0	0	2.3377434766629914	2.3136006694646123	HSD17B7
Aspirin and miRNAs WP4707	1/10	0.3716983643872405	0.9984653905752534	0	0	2.3377434766629914	2.3136006694646123	PTGS1
Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269	1/10	0.3716983643872405	0.9984653905752534	0	0	2.3377434766629914	2.3136006694646123	PRKCQ
Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518	1/10	0.3716983643872405	0.9984653905752534	0	0	2.3377434766629914	2.3136006694646123	GGCT
Interleukin-1 Induced Activation of NF-kappa-B WP3656	1/10	0.3716983643872405	0.9984653905752534	0	0	2.3377434766629914	2.3136006694646123	PRKCZ
Non-homologous end joining WP438	1/10	0.3716983643872405	0.9984653905752534	0	0	2.3377434766629914	2.3136006694646123	NHEJ1
Exercise-induced Circadian Regulation WP410	3/48	0.37283358828618346	0.9984653905752534	0	0	1.4030939226519337	1.3843248796200225	GSTM3;RBPMS;CRY1
Rett syndrome causing genes WP4312	3/48	0.37283358828618346	0.9984653905752534	0	0	1.4030939226519337	1.3843248796200225	TCF4;SMARCA1;SHANK3
Statin inhibition of cholesterol production WP430	2/29	0.3816905480558857	0.9984653905752534	0	0	1.5587441746382145	1.5012967863571316	HMGCR;FDFT1
RAS and bradykinin pathways in COVID-19 WP4969	2/29	0.3816905480558857	0.9984653905752534	0	0	1.5587441746382145	1.5012967863571316	REN;PRKG1
Dopaminergic Neurogenesis WP2855	2/30	0.39797895251073495	0.9984653905752534	0	0	1.5029959003468938	1.384794528586447	ALDH1A1;SLC18A2
Extracellular vesicle-mediated signaling in recipient cells WP2870	2/30	0.39797895251073495	0.9984653905752534	0	0	1.5029959003468938	1.384794528586447	SMAD4;PROM1
One-carbon metabolism WP241	2/30	0.39797895251073495	0.9984653905752534	0	0	1.5029959003468938	1.384794528586447	DNMT3B;AMT
Gene regulatory network modelling somitogenesis  WP2854	1/11	0.40023747905283874	0.9984653905752534	0	0	2.103858875413451	1.9264977033140442	HES1
Glycolysis in senescence WP5049	1/11	0.40023747905283874	0.9984653905752534	0	0	2.103858875413451	1.9264977033140442	ALDOC
PTF1A related regulatory pathway WP4147	1/11	0.40023747905283874	0.9984653905752534	0	0	2.103858875413451	1.9264977033140442	HES1
16p11.2 distal deletion syndrome WP4950	2/31	0.41406457098413774	0.9984653905752534	0	0	1.4510923346273883	1.279476503567977	CD82;MPL
Trans-sulfuration and one-carbon metabolism WP2525	2/31	0.41406457098413774	0.9984653905752534	0	0	1.4510923346273883	1.279476503567977	DNMT3B;AMT
One-carbon metabolism and related pathways WP3940	3/52	0.42231341377418236	0.9984653905752534	0	0	1.288285037772015	1.1105114341779705	PCYT1B;ETNK2;BCAT1
Biomarkers for urea cycle disorders WP4583	1/12	0.4274816321367295	0.9984653905752534	0	0	1.9124987471183723	1.6253255035640346	GATM
Computational Model of Aerobic Glycolysis WP4629	1/12	0.4274816321367295	0.9984653905752534	0	0	1.9124987471183723	1.6253255035640346	PFKM
Iron metabolism in placenta WP2007	1/12	0.4274816321367295	0.9984653905752534	0	0	1.9124987471183723	1.6253255035640346	SLC40A1
RalA downstream regulated genes WP2290	1/12	0.4274816321367295	0.9984653905752534	0	0	1.9124987471183723	1.6253255035640346	RALA
Arrhythmogenic Right Ventricular Cardiomyopathy WP2118	4/74	0.43473960118637694	0.9984653905752534	0	0	1.202402022756005	1.0016105583991508	CACNB2;PKP2;DSG2;ITGA9
Epithelial to mesenchymal transition in colorectal cancer WP4239	8/160	0.4415844459400844	0.9984653905752534	0	0	1.1076023391812866	0.9053386530300209	FZD3;SMAD4;CLDN15;AKT3;FZD6;ID1;PKP2;LRP6
Vitamin D Receptor Pathway WP2877	9/182	0.4450576314069774	0.9984653905752534	0	0	1.0948002597619706	0.8862971885731805	ABCB1;CDKN1B;TNFSF4;TPM1;ID1;NRIP1;PRKCQ;BMP6;HLA-DRB1
Endothelin Pathways WP2197	2/33	0.44556858713233627	0.9984653905752534	0	0	1.357331054617959	1.0972719740249515	GNB5;GNAI1
miRNA regulation of prostate cancer signaling pathways WP3981	2/33	0.44556858713233627	0.9984653905752534	0	0	1.357331054617959	1.0972719740249515	CDKN1B;AKT3
Monoamine GPCRs WP58	2/33	0.44556858713233627	0.9984653905752534	0	0	1.357331054617959	1.0972719740249515	CHRM3;HTR1F
Pregnane X receptor pathway WP2876	2/33	0.44556858713233627	0.9984653905752534	0	0	1.357331054617959	1.0972719740249515	ABCB1;NRIP1
Regucalcin in proximal tubule epithelial kidney cells WP4838	2/33	0.44556858713233627	0.9984653905752534	0	0	1.357331054617959	1.0972719740249515	SMAD4;PRKCQ
Resistin as a regulator of inflammation WP4481	2/33	0.44556858713233627	0.9984653905752534	0	0	1.357331054617959	1.0972719740249515	PLCB4;AKT3
Development of pulmonary dendritic cells and macrophage subsets WP3892	1/13	0.4534895204423102	0.9984653905752534	0	0	1.75303197353914	1.386268089760494	TCF4
Genes targeted by miRNAs in adipocytes WP1992	1/13	0.4534895204423102	0.9984653905752534	0	0	1.75303197353914	1.386268089760494	ERG
Irinotecan pathway WP229	1/13	0.4534895204423102	0.9984653905752534	0	0	1.75303197353914	1.386268089760494	ABCC1
Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814	1/13	0.4534895204423102	0.9984653905752534	0	0	1.75303197353914	1.386268089760494	NRIP1
NO metabolism in cystic fibrosis WP4947	1/13	0.4534895204423102	0.9984653905752534	0	0	1.75303197353914	1.386268089760494	DDAH2
Joubert Syndrome WP4656	4/76	0.4550611284947217	0.9984653905752534	0	0	1.1688790560471976	0.920285973697186	TCTN2;TMEM67;BBS9;NPHP3
Regulatory circuits of the STAT3 signaling pathway WP4538	4/78	0.47513400635617364	0.9984653905752534	0	0	1.1371681415929205	0.8462332203334587	PTPRD;DEPTOR;MPL;IL12RB2
The influence of laminopathies on Wnt signaling WP4844	2/35	0.4761020074791399	0.9984653905752534	0	0	1.2749347782460365	0.9461586089378522	HMGA2;HES1
Cancer immunotherapy by CTLA4 blockade WP4582	1/14	0.47831718317047955	0.9984653905752534	0	0	1.618098549741328	1.193317265736726	HLA-DRB1
Omega-3/Omega-6 FA synthesis WP4723	1/14	0.47831718317047955	0.9984653905752534	0	0	1.618098549741328	1.193317265736726	FADS1
Neural Crest Differentiation WP2064	5/101	0.4868394061526346	0.9984653905752534	0	0	1.0956533776301218	0.7886742790157961	FZD3;ID1;TCF4;HES1;CDH7
Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877	2/36	0.4909801543406373	0.9984653905752534	0	0	1.237371769900013	0.8802063522594755	BST2;IFITM2
Wnt signaling pathway and pluripotency WP399	5/102	0.49555082426978	0.9984653905752534	0	0	1.0843008984941376	0.7612717853528516	FZD3;FZD6;PRKCQ;PRKCZ;LRP6
Male infertility WP4673	7/146	0.49620176182949205	0.9984653905752534	0	0	1.0593425370691238	0.742358284467068	PACRG;ABLIM1;ABCB1;OR2W3;PMS2;CDC42BPA;REC8
Codeine and Morphine Metabolism WP1604	1/15	0.5020181219414614	0.9984653905752534	0	0	1.5024413293432037	1.035360957268748	ABCB1
Fatty Acid Omega Oxidation WP206	1/15	0.5020181219414614	0.9984653905752534	0	0	1.5024413293432037	1.035360957268748	ALDH1A1
GPCRs, Class C Metabotropic glutamate, pheromone WP501	1/15	0.5020181219414614	0.9984653905752534	0	0	1.5024413293432037	1.035360957268748	GABBR1
Major receptors targeted by epinephrine and norepinephrine WP4589	1/15	0.5020181219414614	0.9984653905752534	0	0	1.5024413293432037	1.035360957268748	ADCY6
miRNAs involved in DNA damage response WP1545	1/15	0.5020181219414614	0.9984653905752534	0	0	1.5024413293432037	1.035360957268748	CDKN1B
Electron Transport Chain (OXPHOS system in mitochondria) WP111	5/103	0.5042063374900337	0.9984653905752534	0	0	1.0731801026058263	0.7348812114450676	SLC25A27;SDHC;SDHA;COX7C;SLC25A4
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850	2/37	0.5055889041848147	0.9984653905752534	0	0	1.2019552191737621	0.8197711795083971	DEPTOR;IGF1R
Amyotrophic lateral sclerosis (ALS) WP2447	2/38	0.5199220326596244	0.9984653905752534	0	0	1.1685062545989697	0.7642923828963508	CCS;ALS2
Striated Muscle Contraction Pathway WP383	2/38	0.5199220326596244	0.9984653905752534	0	0	1.1685062545989697	0.7642923828963508	TPM2;TPM1
Nuclear receptors WP170	2/38	0.5199220326596244	0.9984653905752534	0	0	1.1685062545989697	0.7642923828963508	THRB;NR1H3
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453	1/16	0.5246434155653059	0.9984653905752534	0	0	1.402205071664829	0.9044733894567818	SDHA
Tryptophan catabolism leading to NAD+ production WP4210	1/16	0.5246434155653059	0.9984653905752534	0	0	1.402205071664829	0.9044733894567818	AADAT
Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291	1/16	0.5246434155653059	0.9984653905752534	0	0	1.402205071664829	0.9044733894567818	SYTL4
Hedgehog Signaling Pathway Netpath WP47	1/16	0.5246434155653059	0.9984653905752534	0	0	1.402205071664829	0.9044733894567818	SMO
MAPK pathway in congenital thyroid cancer WP4928	1/16	0.5246434155653059	0.9984653905752534	0	0	1.402205071664829	0.9044733894567818	ALK
Pathways of nucleic acid metabolism and innate immune sensing WP4705	1/16	0.5246434155653059	0.9984653905752534	0	0	1.402205071664829	0.9044733894567818	DDX58
Modulators of TCR signaling and T cell activation WP5072	3/61	0.5277930864607663	0.9984653905752534	0	0	1.08786435511526	0.6952007537247528	CDKN1B;RHOH;PRKCQ
Notch Signaling Pathway Netpath WP61	3/61	0.5277930864607663	0.9984653905752534	0	0	1.08786435511526	0.6952007537247528	FHL1;HES1;GATA3
MicroRNAs in cardiomyocyte hypertrophy WP1544	4/84	0.5334911782370049	0.9984653905752534	0	0	1.0515486725663716	0.6607014319257948	MYEF2;PRKG1;IGF1R;LRP6
Kisspeptin/kisspeptin receptor system in the ovary WP4871	2/39	0.533974434109063	0.9984653905752534	0	0	1.1368653421633554	0.7132776345357061	PLCB4;PRKCQ
Proteasome Degradation WP183	3/62	0.5388539774040957	0.9984653905752534	0	0	1.0693697911789493	0.6612027399606273	UCHL1;PSMC6;NEDD4
ACE Inhibitor Pathway WP554	1/17	0.5462418297920505	0.9984653905752534	0	0	1.3144983461962514	0.7948685920172489	REN
Sulfation Biotransformation Reaction WP692	1/17	0.5462418297920505	0.9984653905752534	0	0	1.3144983461962514	0.7948685920172489	SULT1C4
Canonical and non-canonical TGF-B signaling WP3874	1/17	0.5462418297920505	0.9984653905752534	0	0	1.3144983461962514	0.7948685920172489	SMAD4
Drug Induction of Bile Acid Pathway WP2289	1/17	0.5462418297920505	0.9984653905752534	0	0	1.3144983461962514	0.7948685920172489	ABCB1
Leptin Insulin Overlap WP3935	1/17	0.5462418297920505	0.9984653905752534	0	0	1.3144983461962514	0.7948685920172489	SOCS2
Mitochondrial LC-Fatty Acid Beta-Oxidation WP368	1/17	0.5462418297920505	0.9984653905752534	0	0	1.3144983461962514	0.7948685920172489	PECR
Nephrogenesis WP5052	1/17	0.5462418297920505	0.9984653905752534	0	0	1.3144983461962514	0.7948685920172489	MEIS1
Ferroptosis WP4313	2/40	0.547742033048704	0.9984653905752534	0	0	1.1068897409085627	0.6662932153931174	SLC40A1;CP
Breast cancer pathway WP4262	7/154	0.55303976154884	0.9984653905752534	0	0	1.0012684319010623	0.5930767029155312	FGF16;FZD3;AKT3;FZD6;HES1;IGF1R;LRP6
MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560	1/18	0.566859921795209	0.9984653905752534	0	0	1.2371100590180946	0.7022369360980728	PRKCQ
Splicing factor NOVA regulated synaptic proteins WP4148	2/42	0.5744111804279931	0.9984653905752534	0	0	1.0514348785871965	0.5829257974954568	PLCB4;PRKCZ
Tryptophan metabolism WP465	2/42	0.5744111804279931	0.9984653905752534	0	0	1.0514348785871965	0.5829257974954568	AADAT;ALDH1A1
Cytoplasmic Ribosomal Proteins WP477	4/89	0.5795429846401046	0.9984653905752534	0	0	0.9894325871941697	0.5397507566763702	RPS6KA6;RPS7;RPL23;RPL22
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706	7/158	0.5803943487717488	0.9984653905752534	0	0	0.9745389596548353	0.5301954795866438	THRB;HES1;GATA3;AVP;GATA2;SLC25A4;PBX1
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680	3/66	0.5815616728283501	0.9984653905752534	0	0	1.0012628255722178	0.5427227542417663	FZD3;CDKN1B;FZD6
Small Ligand GPCRs WP247	1/19	0.5865421402239261	0.9984653905752534	0	0	1.1683204704152885	0.6233115457522966	S1PR4
Mitochondrial Gene Expression WP391	1/19	0.5865421402239261	0.9984653905752534	0	0	1.1683204704152885	0.6233115457522966	MYEF2
Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577	2/44	0.5999144577668815	0.9984653905752534	0	0	1.001261431725008	0.5116127558220434	DEPTOR;CP
Renin-angiotensin-aldosterone system (RAAS) WP4756	2/44	0.5999144577668815	0.9984653905752534	0	0	1.001261431725008	0.5116127558220434	CAMK1D;REN
BMP Signaling Pathway in Eyelid Development WP3927	1/20	0.6053309203174342	0.9984653905752534	0	0	1.1067718911390936	0.5555773481108637	SMAD4
Notch Signaling WP268	2/45	0.6122274606572167	0.9984653905752534	0	0	0.977924944812362	0.479820241096708	HES1;DTX3
Prostaglandin Synthesis and Regulation WP98	2/45	0.6122274606572167	0.9984653905752534	0	0	0.977924944812362	0.479820241096708	ANXA3;PTGS1
Galanin receptor pathway WP4970	1/21	0.623266775370772	0.9984653905752534	0	0	1.0513781697905182	0.49707124502886363	CDKN1B
Aryl Hydrocarbon Receptor Pathway WP2873	2/46	0.6242485618348376	0.9984653905752534	0	0	0.9556492073048365	0.45030826504098304	CDKN1B;HES1
Translation inhibitors in chronically activated PDGFRA cells WP4566	2/46	0.6242485618348376	0.9984653905752534	0	0	0.9556492073048365	0.45030826504098304	AKT3;EIF4B
Envelope proteins and their potential roles in EDMD physiopathology WP4535	2/46	0.6242485618348376	0.9984653905752534	0	0	0.9556492073048365	0.45030826504098304	SMAD4;ADCY6
Regulation of Microtubule Cytoskeleton WP2038	2/46	0.6242485618348376	0.9984653905752534	0	0	0.9556492073048365	0.45030826504098304	SPRED1;PHLDB2
Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341	3/71	0.6312840323482782	0.9984653905752534	0	0	0.927396815079623	0.42660196664164435	PLCB4;PRKCQ;PRKCZ
Hippo-Merlin Signaling Dysregulation WP4541	5/120	0.6403285413352325	0.9984653905752534	0	0	0.9137175598247388	0.4073114296420441	PLCB4;CDH9;IGF1R;CDH7;ITGA9
Type II diabetes mellitus WP1584	1/22	0.640388383568391	0.9984653905752534	0	0	1.0012600409513308	0.4462420129636828	PRKCZ
Vitamin D in inflammatory diseases WP4482	1/22	0.640388383568391	0.9984653905752534	0	0	1.0012600409513308	0.4462420129636828	SMAD4
Glycerolipids and Glycerophospholipids WP4722	1/22	0.640388383568391	0.9984653905752534	0	0	1.0012600409513308	0.4462420129636828	AGPAT4
Methionine De Novo and Salvage Pathway WP3580	1/22	0.640388383568391	0.9984653905752534	0	0	1.0012600409513308	0.4462420129636828	MSRB3
Purine metabolism and related disorders WP4224	1/22	0.640388383568391	0.9984653905752534	0	0	1.0012600409513308	0.4462420129636828	PPAT
Primary focal segmental glomerulosclerosis (FSGS) WP2572	3/72	0.6407219293947507	0.9984653905752534	0	0	0.9139082392505404	0.4068351392533253	CDKN1B;MME;LRP6
Differentiation Pathway WP2848	2/48	0.647419946571026	0.9984653905752534	0	0	0.9140032632690277	0.3973721754489962	ALK;NOG
Chromosomal and microsatellite instability in colorectal cancer  WP4216	3/73	0.6499886266174124	0.9984653905752534	0	0	0.9008050513022888	0.3880671888156115	RALA;SMAD4;AKT3
Head and Neck Squamous Cell Carcinoma WP4674	3/73	0.6499886266174124	0.9984653905752534	0	0	0.9008050513022888	0.3880671888156115	SMAD4;AKT3;IGF1R
Cancer immunotherapy by PD-1 blockade WP4585	1/23	0.6567326707913229	0.9984653905752534	0	0	0.9556981056429789	0.4018502546357021	HLA-DRB1
DNA Mismatch Repair WP531	1/23	0.6567326707913229	0.9984653905752534	0	0	0.9556981056429789	0.4018502546357021	PMS2
Kynurenine Pathway and links to Cellular Senescence WP5044	1/23	0.6567326707913229	0.9984653905752534	0	0	0.9556981056429789	0.4018502546357021	AADAT
Hepatitis C and Hepatocellular Carcinoma WP3646	2/49	0.6585738803685189	0.9984653905752534	0	0	0.8945094171246066	0.3736174134370404	UCHL1;SMAD4
Synaptic signaling pathways associated with autism spectrum disorder WP4539	2/50	0.6694431207036386	0.9984653905752534	0	0	0.8758278145695364	0.35147765041636037	AKT3;SHANK3
Triacylglyceride synthesis WP325	1/24	0.6723348902873593	0.9984653905752534	0	0	0.9140980777527443	0.36289576129340384	AGPAT4
Synaptic Vesicle Pathway WP2267	2/51	0.6800304976164503	0.9984653905752534	0	0	0.857908726404469	0.33082473187572037	SLC25A4;SLC18A2
IL-7 signaling pathway WP205	1/25	0.6872286979904724	0.9984653905752534	0	0	0.8759647188533627	0.32856398448434243	CDKN1B
Mammalian disorder of sexual development WP4842	1/25	0.6872286979904724	0.9984653905752534	0	0	0.8759647188533627	0.32856398448434243	PBX1
MTHFR deficiency WP4288	1/25	0.6872286979904724	0.9984653905752534	0	0	0.8759647188533627	0.32856398448434243	DNMT3B
Physiological and pathological hypertrophy of the heart WP1528	1/25	0.6872286979904724	0.9984653905752534	0	0	0.8759647188533627	0.32856398448434243	MYEF2
Relationship between inflammation, COX-2 and EGFR WP4483	1/25	0.6872286979904724	0.9984653905752534	0	0	0.8759647188533627	0.32856398448434243	AKT3
Translation Factors WP107	2/52	0.6903391704392037	0.9984653905752534	0	0	0.8407064017660044	0.3115424635656266	GSPT2;EIF4B
Wnt Signaling Pathway WP363	2/52	0.6903391704392037	0.9984653905752534	0	0	0.8407064017660044	0.3115424635656266	TCF4;LRP6
Nuclear Receptors Meta-Pathway WP2882	13/319	0.6944301731457903	0.9984653905752534	0	0	0.8917296527549567	0.3251814028894156	GSTM3;ABCB1;CDKN1B;TXNRD3;SLC2A10;NR1H3;SMARCA1;SLC5A3;CES4A;ETNK2;SCD;NRIP1;HES1
Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864	2/53	0.7003725930436713	0.9984653905752534	0	0	0.824178678093754	0.29352531016929767	BEX3;CDKN1B
7q11.23 copy number variation syndrome WP4932	4/104	0.7006404157904238	0.9984653905752534	0	0	0.840353982300885	0.29896473820195935	TRIM50;ELN;PRKG1;FBN1
Cytokines and Inflammatory Response WP530	1/26	0.7014462252867066	0.9984653905752534	0	0	0.8408820286659316	0.298186049973001	HLA-DRB1
Glucuronidation WP698	1/26	0.7014462252867066	0.9984653905752534	0	0	0.8408820286659316	0.298186049973001	PGM5
PPAR-alpha pathway WP2878	1/26	0.7014462252867066	0.9984653905752534	0	0	0.8408820286659316	0.298186049973001	NR1H3
Senescence and Autophagy in Cancer WP615	4/105	0.7077415139406329	0.9984653905752534	0	0	0.8319898361517568	0.28759920585057375	GABARAPL2;SMAD4;CDKN1B;IGF1R
TGF-beta Receptor Signaling WP560	2/54	0.7101344799899322	0.9984653905752534	0	0	0.8082866361012057	0.27667725790488046	SMAD4;NOG
Canonical and non-canonical Notch signaling WP3845	1/27	0.7150181474663228	0.9984653905752534	0	0	0.8084980069544568	0.2712085183909745	HES1
Eicosanoid Synthesis WP167	1/27	0.7150181474663228	0.9984653905752534	0	0	0.8084980069544568	0.2712085183909745	PTGS1
Photodynamic therapy-induced unfolded protein response WP3613	1/27	0.7150181474663228	0.9984653905752534	0	0	0.8084980069544568	0.2712085183909745	DNAJB9
Myometrial relaxation and contraction pathways WP289	6/156	0.7167367982542089	0.9984653905752534	0	0	0.84	0.2797591383612431	PKIA;PRKCQ;GNB5;PRKCZ;RYR3;ADCY6
The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879	2/55	0.7196287760967411	0.9984653905752534	0	0	0.7929942938064892	0.2609108149791186	HMGA2;HES1
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	5/132	0.7210668342143919	0.9984653905752534	0	0	0.8268588519458323	0.27040223396389756	RPS6KA6;THRB;SCD;NR1H3;SLC16A2
Nanoparticle-mediated activation of receptor signaling WP2643	1/28	0.7279737499204754	0.9984653905752534	0	0	0.7785128016660542	0.24717025457573596	AKT3
Thermogenesis WP4321	4/108	0.728306008914764	0.9984653905752534	0	0	0.80786249149081	0.2561198586987269	RPS6KA6;PRKG2;PRKG1;ADCY6
Alzheimer's disease WP2059	3/83	0.7332426189302357	0.9984653905752534	0	0	0.7877900552486188	0.2444344249110504	PLCB4;MME;RYR3
Insulin Signaling WP481	6/160	0.7390023901072557	0.9984653905752534	0	0	0.8180090419558269	0.24741020804023223	EHD2;RPS6KA6;PRKCQ;PRKCZ;PFKM;IGF1R
Selective expression of chemokine receptors during T-cell polarization WP4494	1/29	0.7403409911151293	0.9984653905752534	0	0	0.7506693967553946	0.22568455047210825	IL12RB2
Lipid Metabolism Pathway WP3965	1/29	0.7403409911151293	0.9984653905752534	0	0	0.7506693967553946	0.22568455047210825	AKT3
Sphingolipid pathway WP1422	1/30	0.7521465625510657	0.9984653905752534	0	0	0.7247462266661597	0.20642517507873914	B4GALT6
Autophagy WP4923	1/30	0.7521465625510657	0.9984653905752534	0	0	0.7247462266661597	0.20642517507873914	DEPTOR
Cell migration and invasion through p75NTR WP4561	1/30	0.7521465625510657	0.9984653905752534	0	0	0.7247462266661597	0.20642517507873914	AKT3
Eicosanoid metabolism via cyclooxygenases (COX) WP4719	1/30	0.7521465625510657	0.9984653905752534	0	0	0.7247462266661597	0.20642517507873914	PTGS1
Glycerophospholipid Biosynthetic Pathway WP2533	1/30	0.7521465625510657	0.9984653905752534	0	0	0.7247462266661597	0.20642517507873914	LPIN1
Inflammatory Response Pathway WP453	1/30	0.7521465625510657	0.9984653905752534	0	0	0.7247462266661597	0.20642517507873914	THBS3
Matrix Metalloproteinases WP129	1/30	0.7521465625510657	0.9984653905752534	0	0	0.7247462266661597	0.20642517507873914	MMP28
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844	1/30	0.7521465625510657	0.9984653905752534	0	0	0.7247462266661597	0.20642517507873914	CDKN1B
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336	3/86	0.7549469745425282	0.9984653905752534	0	0	0.7591958996205818	0.21341586223091175	FZD3;FZD6;LRP6
MET in type 1 papillary renal cell carcinoma WP4205	2/59	0.7550154641956432	0.9984653905752534	0	0	0.7371906587661206	0.207163142418612	ALK;AKT3
Ectoderm Differentiation WP2858	5/138	0.7562361486896658	0.9984653905752534	0	0	0.7893071549305156	0.22053367060281456	SOCS2;SMAD4;TSC22D1;FHL2;SERPINB6
Chemokine signaling pathway WP3929	6/164	0.7599903004737749	0.9984653905752534	0	0	0.7971315501417384	0.21877244171408816	PLCB4;AKT3;GNB5;PRKCZ;ADCY6;GNAI1
Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865	2/60	0.76323715216403	0.9984653905752534	0	0	0.7244424145543122	0.19573454636598941	CASP10;DDX58
Tumor suppressor activity of SMARCB1 WP4204	1/31	0.763415946023863	0.9984653905752534	0	0	0.7005512679162073	0.18911539152283696	SMO
Type I interferon induction and signaling during SARS-CoV-2 infection WP4868	1/31	0.763415946023863	0.9984653905752534	0	0	0.7005512679162073	0.18911539152283696	DDX58
Ethanol effects on histone modifications WP3996	1/31	0.763415946023863	0.9984653905752534	0	0	0.7005512679162073	0.18911539152283696	ALDH1A1
GABA receptor Signaling WP4159	1/31	0.763415946023863	0.9984653905752534	0	0	0.7005512679162073	0.18911539152283696	GABBR1
SARS coronavirus and innate immunity WP4912	1/31	0.763415946023863	0.9984653905752534	0	0	0.7005512679162073	0.18911539152283696	DDX58
Ciliary landscape WP4352	8/216	0.7694843173940342	0.9984653905752534	0	0	0.807008547008547	0.21146424748847184	IFT88;PSMC6;IFT81;IFT172;BBS9;EFHC2;DYNLL1;RPGR
Prader-Willi and Angelman Syndrome WP3998	2/61	0.7712182955447369	0.9984653905752534	0	0	0.7121263142140907	0.1849988888817994	NDN;PRKCZ
Wnt signaling WP428	4/115	0.7720384889722457	0.9984653905752534	0	0	0.7566371681415929	0.19575782945645567	FZD3;PLCB4;FZD6;LRP6
Constitutive Androstane Receptor Pathway WP2875	1/32	0.7741734685662681	0.9984653905752534	0	0	0.6779172742468969	0.17351923836940283	ABCB1
Development and heterogeneity of the ILC family WP3893	1/32	0.7741734685662681	0.9984653905752534	0	0	0.6779172742468969	0.17351923836940283	GATA3
Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839	1/32	0.7741734685662681	0.9984653905752534	0	0	0.6779172742468969	0.17351923836940283	SMO
SARS-CoV-2 mitochondrial interactions WP5038	1/32	0.7741734685662681	0.9984653905752534	0	0	0.6779172742468969	0.17351923836940283	DDX58
Pancreatic adenocarcinoma pathway WP4263	3/89	0.7752059678231417	0.9984653905752534	0	0	0.7325966850828729	0.18653854448981275	RALA;SMAD4;AKT3
Fluoropyrimidine Activity WP1601	1/33	0.7844423547234424	0.9984653905752534	0	0	0.6566979051819184	0.1594345554472247	PPAT
Host-pathogen interaction of human coronaviruses - interferon induction WP4880	1/33	0.7844423547234424	0.9984653905752534	0	0	0.6566979051819184	0.1594345554472247	DDX58
Purinergic signaling WP4900	1/33	0.7844423547234424	0.9984653905752534	0	0	0.6566979051819184	0.1594345554472247	GNAI1
Genotoxicity pathway WP4286	2/63	0.7864784709306099	0.9984653905752534	0	0	0.6887055332392429	0.16542013390128021	HIST1H2BG;HIST1H2BB
Signaling of Hepatocyte Growth Factor Receptor WP313	1/34	0.7942447762178336	0.9984653905752534	0	0	0.6367645584845144	0.14668736512696032	DOCK1
CAMKK2  Pathway WP4874	1/34	0.7942447762178336	0.9984653905752534	0	0	0.6367645584845144	0.14668736512696032	CHRM3
Type 2 papillary renal cell carcinoma WP4241	1/34	0.7942447762178336	0.9984653905752534	0	0	0.6367645584845144	0.14668736512696032	EGLN3
NRF2 pathway WP2884	5/146	0.7978141198320011	0.9984653905752534	0	0	0.7442096086331613	0.1681017993806209	GSTM3;TXNRD3;SLC2A10;SLC5A3;CES4A
Cell cycle WP179	4/120	0.7997476435454332	0.9984653905752534	0	0	0.7238327738785475	0.1617469815819119	SMAD4;CDKN1B;E2F5;CDC14B
DNA Repair Pathways Full Network WP4946	4/120	0.7997476435454332	0.9984653905752534	0	0	0.7238327738785475	0.1617469815819119	FANCL;PMS2;NHEJ1;FANCF
Focal Adhesion WP306	7/198	0.7999083039897111	0.9984653905752534	0	0	0.7688199847754967	0.17164534893135114	AKT3;STYK1;DOCK1;IGF1R;MYLK4;ITGA9;THBS3
Pathways affected in adenoid cystic carcinoma WP3651	2/65	0.8008354898411051	0.9984653905752534	0	0	0.666771785977084	0.1480898362907072	FGF16;MYCN
Mitochondrial CIV Assembly WP4922	1/35	0.8036019000016308	0.9984653905752534	0	0	0.61800376159284	0.13512731455641414	COX7C
Overview of leukocyte-intrinsic Hippo pathway functions WP4542	1/35	0.8036019000016308	0.9984653905752534	0	0	0.61800376159284	0.13512731455641414	RAB13
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258	3/94	0.8058985117738453	0.9984653905752534	0	0	0.6921619816647441	0.1493667977711826	FZD3;FZD6;LRP6
SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039	2/66	0.807687784858985	0.9984653905752534	0	0	0.6563189845474614	0.14017641183191717	LAG3;DDX58
Target Of Rapamycin (TOR) Signaling WP1471	1/36	0.812533933194653	0.9984653905752534	0	0	0.6003150102378327	0.12462395640096244	HMGCR
Zinc homeostasis WP3529	1/36	0.812533933194653	0.9984653905752534	0	0	0.6003150102378327	0.12462395640096244	SLC30A4
Histone Modifications WP2369	2/67	0.8143292713047914	0.9984653905752534	0	0	0.6461878077772117	0.1327208269621648	SETBP1;HIST1H4H
PPAR signaling pathway WP3942	2/67	0.8143292713047914	0.9984653905752534	0	0	0.6461878077772117	0.1327208269621648	SCD;NR1H3
Regulation of Actin Cytoskeleton WP51	5/150	0.8164077282322068	0.9984653905752534	0	0	0.7235269408485127	0.14676120449375324	CHRM3;FGF16;GNA12;MYH10;DOCK1
Melanoma WP4685	2/68	0.8207649413347587	0.9984653905752534	0	0	0.6363636363636364	0.12569360253967538	PREX2;AKT3
Melatonin metabolism and effects WP3298	1/37	0.8210601673846647	0.9984653905752534	0	0	0.583608967291437	0.11506369427574889	CRY1
Hepatitis B infection WP4666	5/152	0.825177209396151	0.9984653905752534	0	0	0.7136077022170995	0.13712479833130406	SMAD4;CASP10;DDX58;AKT3;HSPG2
Parkinson's disease pathway WP2371	1/38	0.829199019213266	0.9984653905752534	0	0	0.5678059536934951	0.10634726222105599	UCHL1
Nonalcoholic fatty liver disease WP4396	5/155	0.8376924217889592	0.9984653905752534	0	0	0.6992248062015504	0.12383570887632263	AKT3;NR1H3;SDHC;SDHA;COX7C
Integrin-mediated Cell Adhesion WP185	3/101	0.8428735878172512	0.9984653905752534	0	0	0.6424850603224715	0.10982529586870823	AKT3;DOCK1;ITGA9
Glycogen Synthesis and Degradation WP500	1/40	0.8443841059576789	0.9984653905752534	0	0	0.538631159358833	0.09110826811279996	PHKA1
IL-5 signaling pathway WP127	1/40	0.8443841059576789	0.9984653905752534	0	0	0.538631159358833	0.09110826811279996	SPRED1
Neural Crest Cell Migration during Development WP4564	1/40	0.8443841059576789	0.9984653905752534	0	0	0.538631159358833	0.09110826811279996	AKT3
Oxidative Damage WP3941	1/40	0.8443841059576789	0.9984653905752534	0	0	0.538631159358833	0.09110826811279996	CDKN1B
MECP2 and Associated Rett Syndrome WP3584	2/72	0.8445484881177546	0.9984653905752534	0	0	0.5998738568274992	0.10135056452871824	PSIP1;IGF1R
Non-small cell lung cancer WP4255	2/72	0.8445484881177546	0.9984653905752534	0	0	0.5998738568274992	0.10135056452871824	ALK;AKT3
Common Pathways Underlying Drug Addiction WP2636	1/42	0.8582204976401623	0.9984653905752534	0	0	0.5123026864226746	0.0783281207991861	GNAI1
Fas ligand pathway and stress induction of heat shock proteins WP314	1/42	0.8582204976401623	0.9984653905752534	0	0	0.5123026864226746	0.0783281207991861	CASP10
IL-2 signaling pathway WP49	1/42	0.8582204976401623	0.9984653905752534	0	0	0.5123026864226746	0.0783281207991861	NMI
Metabolic reprogramming in colon cancer WP4290	1/42	0.8582204976401623	0.9984653905752534	0	0	0.5123026864226746	0.0783281207991861	PPAT
Cytosolic DNA-sensing pathway WP4655	2/75	0.8604652779107148	0.9984653905752534	0	0	0.5751307871420364	0.0864318136993932	CASP10;DDX58
Vitamin A and carotenoid metabolism WP716	1/43	0.864670754366068	0.9984653905752534	0	0	0.5000787525594582	0.07271468878170018	ALDH1A1
Eukaryotic Transcription Initiation WP405	1/43	0.864670754366068	0.9984653905752534	0	0	0.5000787525594582	0.07271468878170018	TAF9
Neural Crest Cell Migration in Cancer WP4565	1/43	0.864670754366068	0.9984653905752534	0	0	0.5000787525594582	0.07271468878170018	AKT3
Heart Development WP1591	1/44	0.8708278608384802	0.9984653905752534	0	0	0.4884233737596472	0.06755430356282593	SMAD4
Hedgehog Signaling Pathway WP4249	1/44	0.8708278608384802	0.9984653905752534	0	0	0.4884233737596472	0.06755430356282593	SMO
Integrated Cancer Pathway WP1971	1/44	0.8708278608384802	0.9984653905752534	0	0	0.4884233737596472	0.06755430356282593	CDKN1B
ATM Signaling Network in Development and Disease  WP3878	1/45	0.8767051259158889	0.9984653905752534	0	0	0.47729778490528213	0.06280502549489037	RNF8
Nephrotic syndrome WP4758	1/45	0.8767051259158889	0.9984653905752534	0	0	0.47729778490528213	0.06280502549489037	GPC5
DNA damage response (only ATM dependent) WP710	3/110	0.8813273386652559	0.9984653905752534	0	0	0.5881654360510146	0.07430068599153404	SMAD4;CDKN1B;AKT3
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203	1/47	0.8876703773907355	0.9984653905752534	0	0	0.4564977709601649	0.054393901298807563	TNFSF4
Endoplasmic reticulum stress response in coronavirus infection WP4861	1/47	0.8876703773907355	0.9984653905752534	0	0	0.4564977709601649	0.054393901298807563	PPP1R9A
NO/cGMP/PKG mediated Neuroprotection WP4008	1/47	0.8876703773907355	0.9984653905752534	0	0	0.4564977709601649	0.054393901298807563	PRKG2
Gastrin signaling pathway WP4659	3/114	0.8955532559342352	0.9984653905752534	0	0	0.5668508287292817	0.06253134913861576	CDKN1B;PRKCQ;TCF4
Phosphoinositides metabolism WP4971	1/49	0.8976613927681941	0.9984653905752534	0	0	0.4374310915104741	0.0472260885915511	PLCB4
Circadian rhythm related genes WP3594	6/201	0.8983107168956368	0.9984653905752534	0	0	0.6446187958383081	0.06912844304842557	NRIP1;CRY1;ID3;NR1H3;PRKG2;AVP
Apoptosis WP254	2/84	0.8996668165829348	0.9984653905752534	0	0	0.5117643891670705	0.054109252135390605	CASP10;IGF1R
EGFR Tyrosine Kinase Inhibitor Resistance WP4806	2/84	0.8996668165829348	0.9984653905752534	0	0	0.5117643891670705	0.054109252135390605	AKT3;IGF1R
Copper homeostasis WP3286	1/52	0.9110082635691508	0.9984653905752534	0	0	0.4116349957844218	0.038365744483691955	CCS
Netrin-UNC5B signaling pathway WP4747	1/52	0.9110082635691508	0.9984653905752534	0	0	0.4116349957844218	0.038365744483691955	ROBO4
Cardiac Progenitor Differentiation WP2406	1/53	0.9150589331085967	0.9984653905752534	0	0	0.4036977355610211	0.03583495938732295	NOG
Phosphodiesterases in neuronal function WP4222	1/53	0.9150589331085967	0.9984653905752534	0	0	0.4036977355610211	0.03583495938732295	ADCY6
Selenium Micronutrient Network WP15	2/89	0.9167439368719073	0.9984653905752534	0	0	0.4822257745299536	0.04191848126445916	TXNRD3;PTGS1
Integrated breast cancer pathway WP1984	4/152	0.9186210023349962	0.9984653905752534	0	0	0.5663716814159292	0.048074559396619046	SMAD4;RALA;PKIA;HMGCR
IL-4 signaling pathway WP395	1/54	0.9189254158911837	0.9984653905752534	0	0	0.3960599945913337	0.03348699841790396	GATA3
Interferon type I signaling pathways WP585	1/54	0.9189254158911837	0.9984653905752534	0	0	0.3960599945913337	0.03348699841790396	EIF4B
Androgen receptor signaling pathway WP138	2/90	0.9198143261456257	0.9984653905752534	0	0	0.47672085089303634	0.039845972791634876	SMAD4;FHL2
T-cell receptor (TCR) signaling pathway WP69	2/90	0.9198143261456257	0.9984653905752534	0	0	0.47672085089303634	0.039845972791634876	PRKCQ;GATA3
Cardiac Hypertrophic Response WP2795	1/55	0.9226160781853069	0.9984653905752534	0	0	0.3887051329168198	0.031307120289701645	PRKG1
DNA IR-double strand breaks and cellular response via ATM WP3959	1/55	0.9226160781853069	0.9984653905752534	0	0	0.3887051329168198	0.031307120289701645	RNF8
IL-1 signaling pathway WP195	1/55	0.9226160781853069	0.9984653905752534	0	0	0.3887051329168198	0.031307120289701645	PRKCZ
Pathogenic Escherichia coli infection WP2272	1/55	0.9226160781853069	0.9984653905752534	0	0	0.3887051329168198	0.031307120289701645	KRT18
RANKL/RANK signaling pathway WP2018	1/55	0.9226160781853069	0.9984653905752534	0	0	0.3887051329168198	0.031307120289701645	FHL2
ErbB signaling pathway WP673	2/91	0.9227779264098668	0.9984653905752534	0	0	0.4713396334052633	0.03787999828440866	CDKN1B;AKT3
Mitochondrial complex I assembly model OXPHOS system WP4324	1/56	0.9261389065485978	0.9984653905752534	0	0	0.3816177207577428	0.029281927845254404	TMEM126B
mRNA Processing WP411	3/126	0.9294805126589498	0.9984653905752534	0	0	0.5112249023042716	0.03738558951200534	SNRPD2;DHX16;SNRPE
Proximal tubule transport WP4917	1/57	0.929501525256901	0.9984653905752534	0	0	0.37478343046149	0.027399228866839643	ABCB1
Complement and Coagulation Cascades WP558	1/58	0.9327112125482858	0.9984653905752534	0	0	0.3681889398247548	0.02564791331515348	CFH
Small cell lung cancer WP4658	2/96	0.9361085623857426	0.9984653905752534	0	0	0.4461509558029214	0.029456592083196117	CDKN1B;AKT3
22q11.2 copy number variation syndrome WP4657	3/131	0.9403616648956008	0.9984653905752534	0	0	0.4911256906077348	0.030199676169717516	ARVCF;HIST1H4H;HES1
TYROBP causal network in microglia WP3945	1/61	0.941490603178509	0.9984653905752534	0	0	0.3497243660418964	0.021085200846738716	CYTL1
Oxidation by Cytochrome P450 WP43	1/61	0.941490603178509	0.9984653905752534	0	0	0.3497243660418964	0.021085200846738716	CYP51A1
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863	1/62	0.9441549619736107	0.9984653905752534	0	0	0.34397310535543224	0.01976640475637394	PRKCQ
Endometrial cancer WP4155	1/63	0.946698115592845	0.9984653905752534	0	0	0.3384073692072412	0.018536269181328707	AKT3
Lung fibrosis WP3624	1/63	0.946698115592845	0.9984653905752534	0	0	0.3384073692072412	0.018536269181328707	ELN
G1 to S cell cycle control WP45	1/64	0.9491255720071974	0.9984653905752534	0	0	0.3330183230955006	0.0173882749292716	CDKN1B
Oncostatin M Signaling Pathway WP2374	1/65	0.951442589208504	0.9984653905752534	0	0	0.32779768467475195	0.016316435002911883	CDKN1B
AGE/RAGE pathway WP2324	1/66	0.9536541862372	0.9984653905752534	0	0	0.322737681282334	0.015315246039880393	PRKCZ
p53 transcriptional gene network WP4963	1/67	0.9557651546593328	0.9984653905752534	0	0	0.3178310113260499	0.014379644410295093	TP53INP1
DNA damage response WP707	1/68	0.9577800681511813	0.9984653905752534	0	0	0.3130708091296549	0.013504967214491735	CDKN1B
VEGFA-VEGFR2 Signaling Pathway WP3888	13/432	0.9587636887093518	0.9984653905752534	0	0	0.6473220357061906	0.02725915086705698	TRPC1;FHL2;PDE4DIP;PBXIP1;GATA2;PRKCZ;FGD5;ARMCX1;BIN1;TAL1;DNAJB9;ERG;PRKG1
AMP-activated protein kinase (AMPK) signaling WP1403	1/69	0.9597032928715544	0.9984653905752534	0	0	0.30845061288021275	0.01268691677198579	HMGCR
Glucocorticoid Receptor Pathway WP2880	1/70	0.9615389966142518	0.9984653905752534	0	0	0.3039643353626384	0.011921528856417672	ETNK2
Parkin-Ubiquitin Proteasomal System pathway WP2359	1/70	0.9615389966142518	0.9984653905752534	0	0	0.3039643353626384	0.011921528856417672	PSMC6
miRNA regulation of DNA damage response WP1530	1/71	0.963291158265032	0.9984653905752534	0	0	0.29960623720270907	0.011205143796508152	CDKN1B
IL-18 signaling pathway WP4754	7/272	0.9662584981593902	0.9984653905752534	0	0	0.5519611333319373	0.018945449984123917	SPON1;CLDN15;ALS2;BIN1;MUM1;NR1H3;S1PR4
Metapathway biotransformation Phase I and II WP702	4/183	0.9689962261504754	0.9984653905752534	0	0	0.4675186631729866	0.014724295374090006	GSTM3;EPHX2;CYP51A1;SULT1C4
Ras signaling WP4223	4/184	0.9699832983382446	0.9984653905752534	0	0	0.4648967551622419	0.014168391482395173	RALA;AKT3;GNB5;IGF1R
Leptin signaling pathway WP2034	1/76	0.9709258862378412	0.9984653905752534	0	0	0.2795589856670342	0.00824842724976862	SOCS2
Prolactin Signaling Pathway WP2037	1/76	0.9709258862378412	0.9984653905752534	0	0	0.2795589856670342	0.00824842724976862	SOCS2
Spinal Cord Injury WP2431	2/118	0.9728101136618794	0.9984653905752534	0	0	0.3611174545177742	0.009954697862708103	CDKN1B;E2F5
EGF/EGFR signaling pathway WP437	3/162	0.9797834178453659	0.9984653905752534	0	0	0.3947253205462316	0.00806176492649778	RALA;NEDD4;PRKCZ
Retinoblastoma gene in cancer WP2446	1/87	0.9825962853378163	0.9984653905752534	0	0	0.24366041896361632	0.004277931282194297	CDKN1B
TGF-beta Signaling Pathway WP366	2/132	0.9844363416428489	0.9984653905752534	0	0	0.32199015112922397	0.00505075154614391	SMAD4;E2F5
Apoptosis Modulation and Signaling WP1772	1/90	0.9848699082968393	0.9984653905752534	0	0	0.23540998228509843	0.003588994516813839	CASP10
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	7/303	0.9857619714024538	0.9984653905752534	0	0	0.49334073251942284	0.007074684613318591	FGF16;CDKN1B;AKT3;EIF4B;IGF1R;ITGA9;THBS3
TNF-alpha signaling pathway WP231	1/92	0.9862182746307371	0.9984653905752534	0	0	0.2302119049638344	0.003194782980305574	PRKCZ
MAPK Signaling Pathway WP382	5/246	0.9883470822460502	0.9984653905752534	0	0	0.43311138988066517	0.0050766480697027215	CACNB2;FGF16;AKT3;GNA12;MAPK8IP1
Complement system WP2806	1/97	0.9890870067460893	0.9984653905752534	0	0	0.21816427783902978	0.002393911551406815	CFH
Toll-like Receptor Signaling Pathway WP75	1/103	0.9917531905175667	0.9984653905752534	0	0	0.20526622997600363	0.0016998101706938544	AKT3
GPCRs, Class A Rhodopsin-like WP455	5/257	0.9918408013101015	0.9984653905752534	0	0	0.4139640352264937	0.003391469542857129	GPR173;CHRM3;HTR1F;GPR21;F2RL1
PI3K-Akt signaling pathway WP4172	7/340	0.9952533210314654	0.9984653905752534	0	0	0.4376618571957085	0.002082386462047336	CDKN1B;AKT3;GNB5;EIF4B;IGF1R;ITGA9;THBS3
Fragile X Syndrome  WP4549	1/121	0.9964422539001613	0.9984653905752534	0	0	0.1743109151047409	6.212597771186618E-4	DEPTOR
Regulation of toll-like receptor signaling pathway WP1449	1/139	0.9984653905752534	0.9984653905752534	0	0	0.15143089976511193	2.325657804732861E-4	AKT3
